ASO transfection of iPSC-derived cells

By James Evans, MSc
View Published Protocol

Output Details

Description
A protocol for transfecting iPSC-derived midbrain dopaminergic neurons with antisense oligonucleotides (ASOs).
Identifier (DOI)
10.17504/protocols.io.81wgbxbonlpk/v1
Tags
  • Dopaminergic neurons
  • hiPSCs (Human induced pluripotent stem cells)
  • Transfection
Team
Team Wood
Program
Collaborative Research Network
Theme
PD Functional Genomics

Meet the Authors

  • User avatar fallback logo

    James Evans, MSc

    Key Personnel: Team Wood, 

    University College London

Related Research

The diversity of SNCA transcripts in neurons, and its impact on antisense oligonucleotide therapeutics

Long-read RNA sequencing of SNCA in human dopaminergic neuron reveals most expression comes from alternative transcripts. Targeting these with ASOs effective reversal of PD pathology, offering insights for RNA therapies + protein isoform differences.

View Article

Single-cell RNA-sequencing data from A Vulnerable Subtype of Dopaminergic Neurons Drives Early Motor Deficits in Parkinson’s Disease

Single-nucleus RNA profiling of the ventral midbrain of MitoPark mice, their littermate controls and C57BL/6 mice at 8, 16, and 24 weeks of age (8 mice in each group; 4 males and 4 females).

View Dataset

Datasets and Key Resources Table used in Do, Quyen B. et al. (2023) “Early striatal hyperexcitability in an in vitro human striatal microcircuit model carrying the Parkinson’s GBA-N370S mutation”

The files found here are associated to Do, Q. et al (2023) study and contain: (a) all source and supplementary data, (b) Key Resources Table, and (c) list of primers.

View Dataset
View More Outputs